Glaucoma: Advances in Diagnosis, Management, and Vision Preservation

Dear Colleagues,

Glaucoma is a leading cause of irreversible blindness worldwide, resulting from progressive loss of retinal ganglion cells and optic nerve damage. With recent advances in imaging technologies such as optical coherence tomography (OCT) and OCT angiography, the understanding of disease mechanisms and early detection has markedly improved. Therapeutic strategies have also diversified, encompassing pharmacologic treatments, an expanding spectrum of laser therapies—including selective laser trabeculoplasty, micropulse laser, and cyclophotocoagulation—and innovative surgical approaches such as minimally invasive glaucoma surgery (MIGS). In addition, long-tube devices like the Ahmed ClearPath and the Paul Glaucoma Implant are providing new long-term IOP control options for advanced or refractory cases. Artificial intelligence and real-world evidence are further contributing to individualized care.

This Special Issue aims to present cutting-edge research in glaucoma diagnosis, disease mechanisms, and medical, laser, and surgical management. We especially encourage studies focusing on long-term visual function and vision preservation, bridging structural and functional outcomes to optimize patient quality of life.

Prof. Dr. Masaki Tanito
Dr. Takuhei Shoji
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.